Compare QLYS & RDNT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | QLYS | RDNT |
|---|---|---|
| Founded | 1999 | 1985 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Computer Software: Prepackaged Software | Medical Specialities |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.3B | 5.7B |
| IPO Year | 2012 | 1996 |
| Metric | QLYS | RDNT |
|---|---|---|
| Price | $96.61 | $63.09 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 13 | 5 |
| Target Price | ★ $137.46 | $86.00 |
| AVG Volume (30 Days) | ★ 793.2K | 780.6K |
| Earning Date | 05-07-2026 | 06-02-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 16.99 | N/A |
| EPS | ★ 5.44 | N/A |
| Revenue | $321,607,000.00 | ★ $1,616,630,000.00 |
| Revenue This Year | $9.96 | $12.24 |
| Revenue Next Year | $7.15 | $9.52 |
| P/E Ratio | $18.14 | ★ N/A |
| Revenue Growth | ★ 15.32 | 13.05 |
| 52 Week Low | $85.14 | $45.00 |
| 52 Week High | $155.47 | $85.84 |
| Indicator | QLYS | RDNT |
|---|---|---|
| Relative Strength Index (RSI) | 36.24 | 39.62 |
| Support Level | $85.14 | $54.45 |
| Resistance Level | $136.70 | $74.55 |
| Average True Range (ATR) | 4.63 | 3.27 |
| MACD | 1.51 | -0.71 |
| Stochastic Oscillator | 56.84 | 17.66 |
Qualys is a cloud security and compliance solutions provider that helps businesses identify and manage their security risks and compliance requirements. The California-based company has more than 10,000 customers worldwide, the majority of which are small- and medium-size businesses. Qualys was founded in 1999 and went public in 2012.
RadNet Inc is a national provider of diagnostic imaging services that operates in two business segments: Imaging Center segment and Digital Health segment. The Imaging Center segment provides physicians with imaging capabilities to facilitate the diagnosis and treatment of diseases and disorders. Services include magnetic resonance imaging (MRI), computed tomography (CT), positron emission tomography (PET), nuclear medicine, mammography, ultrasound, diagnostic radiology (X-ray), and fluoroscopy. The Digital Health segment develops and deploys clinical applications to enhance the interpretation of medical images and improve patient outcomes with an emphasis on brain, breast, prostate, and pulmonary diagnostics.